Systemic treatment with pulsed electromagnetic fields do not affect bone microarchitecture in osteoporotic rats
Olav P van der Jagt1, Jacqueline C van der Linden, Jan H Waarsing
1Department of Orthopaedics, Erasmus MC, University Medical Center Rotterdam, Dr Molenwaterplein 40, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. o.vanderjagt@erasmusmc.nl
International Orthopaedics
|January 18, 2012
Summary
Pulsed electromagnetic fields (PEMF) did not improve bone microarchitecture in an osteoporotic rat model. Further research in humans is recommended due to the safety of PEMF treatment for osteoporosis.
Area of Science:
- Biomedical Engineering
- Orthopedics
- Bone Biology
Background:
- Pulsed electromagnetic fields (PEMF) are utilized for spinal fusion and non-union treatments.
- Emerging evidence suggests potential efficacy of PEMF in managing osteoporosis.
- This study investigates PEMF's impact on bone microarchitecture in an established osteoporotic model.
Purpose of the Study:
- To evaluate the effect of whole-body PEMF treatment on bone microarchitecture in an ovariectomized rat model of osteoporosis.
- To assess changes in cancellous and cortical bone structure under various PEMF treatment protocols.
- To determine if PEMF can mitigate or reverse bone loss associated with osteoporosis.
Main Methods:
- Ovariectomy was performed on 20-week-old female rats to induce osteoporosis.
- Four distinct PEMF treatment protocols were applied (2 h/day, 5 days/week).
- In vivo microcomputed tomography (microCT) scanning assessed tibial bone microarchitecture at baseline, 3, and 6 weeks.
Main Results:
- No significant differences in cancellous or cortical bone microarchitecture were observed between PEMF-treated groups and the control group.
- PEMF treatment did not induce any measurable changes in bone structure in the osteoporotic rat model.
- In vivo microCT successfully detected subtle bone changes over time, validating the methodology.
Conclusions:
- The study found no evidence supporting the use of PEMF for treating osteoporosis in this rat model.
- Discrepancies with previous studies may stem from variations in experimental setups.
- Future research should prioritize human trials to avoid animal-to-human translation issues, given PEMF's safety profile.


